Quantitative methylation analysis using methylation-sensitive single-nucleotide primer extension (Ms-SNuPE).

[1]  P. Jones,et al.  Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE). , 1997, Nucleic acids research.

[2]  P. Jones,et al.  Mutagenic and epigenetic effects of DNA methylation. , 1997, Mutation research.

[3]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Weissman,et al.  Uniform amplification of a mixture of deoxyribonucleic acids with varying GC content. , 1996, Genome research.

[5]  P. Jones,et al.  DNA methylation errors and cancer. , 1996, Cancer research.

[6]  D. Burke,et al.  Single nucleotide primer extension: quantitative range, variability, and multiplex analysis. , 1996, Genome research.

[7]  J. Mann,et al.  Allele-specific expression and total expression levels of imprinted genes during early mouse development: implications for imprinting mechanisms. , 1995, Genes & development.

[8]  J. Herman,et al.  Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. , 1995, Cancer research.

[9]  R. Beart,et al.  Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. , 1995, Cancer research.

[10]  J. Herman,et al.  5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.

[11]  J. Goodman,et al.  Hypomethylation of DNA: An epigenetic mechanism involved in tumor promotion , 1994, Molecular carcinogenesis.

[12]  J. Herman,et al.  Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  G. Coetzee,et al.  Progressive increases in the methylation status and heterochromatinization of the myoD CpG island during oncogenic transformation , 1994, Molecular and cellular biology.

[14]  T. Sakai,et al.  CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. , 1993, Oncogene.

[15]  Adrian Bird,et al.  The essentials of DNA methylation , 1992, Cell.

[16]  L. E. McDonald,et al.  A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[17]  A. Riggs,et al.  A sensitive, quantitative assay for measurement of allele-specific transcripts differing by a single nucleotide. , 1992, PCR methods and applications.

[18]  T. Dryja,et al.  Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. , 1991, American journal of human genetics.

[19]  S. Spitzer,et al.  Single nucleotide primer extension to detect genetic diseases: experimental application to hemophilia B (factor IX) and cystic fibrosis genes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Bird,et al.  High levels of De Novo methylation and altered chromatin structure at CpG islands in cell lines , 1990, Cell.

[21]  Robert L. Tanguay,et al.  A quantitative HpaII-PCR assay to measure methylation of DNA from a small number of cells. , 1990, Nucleic acids research.

[22]  A. Bird.  CpG-rich islands and the function of DNA methylation , 1986, Nature.

[23]  A. Feinberg,et al.  Hypomethylation of DNA from benign and malignant human colon neoplasms. , 1985, Science.

[24]  M. Ehrlich,et al.  The 5-methylcytosine content of DNA from human tumors. , 1983, Nucleic acids research.

[25]  A. Feinberg,et al.  Hypomethylation distinguishes genes of some human cancers from their normal counterparts , 1983, Nature.